Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteoporosis 1Musculoskeletal Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hyperparathyroidism 1Humoral Hypercalcemia Of Malignancy 1Hodgkin Disease 1Endocrine System Diseases 1Bone Diseases, Endocrine 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3selpercatinib 2parathyroid hormone-related peptide (1-36) 2niraparib 2Ocoxin 2Musculoskeletal Manipulations 2Metformin 2Clomiphene 2Cisplatin 2repotrectinib 1relacorilant 1pralsetinib 1pembrolizumab 1napabucasin 1fluorodopa F 18 1anlotinib 1adrenosterone 1Thalidomide 1Sunitinib 1Spironolactone 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Paclitaxel 1Octreotide 1Melphalan 1Leuprolide 1Irinotecan 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endocrine System Diseases × Parathyroid Hormone × Clear all
NCT01333267 2014-12-05

One Week Comparison Study of PTH and PTHrP Infusions

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Humoral Hypercalcemia Of Malignancy, Bone Diseases, Endocrine, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡